Literature DB >> 3666958

Characterization of cyclophosphamide-rat model of cryptosporidiosis.

J E Rehg1, M L Hancock, D B Woodmansee.   

Abstract

A cyclophosphamide-treated-rat model for cryptosporidiosis is described. The optimal conditions for inducing a cryptosporidial infection in rats were a 50 mg/kg dose of cyclophosphamide per day in the drinking water for a minimum of 14 days before inoculation with 10(4) or more infectious oocysts. Eighteen days after inoculation, 80% or more of the animals were infected. Cryptosporidia were attached to the terminal 24 cm of the small intestine, and the immunosuppressed animals remained infected as long as they received cyclophosphamide. However, the intestinal infection cleared within 7 to 10 days after cyclophosphamide was withdrawn. Oocysts continued to be detected in the feces for an additional 5 to 7 days after cryptosporidia were no longer visibly attached to the ideal enterocytes. This study characterized an animal model that can be used to investigate the pathogenesis of and evaluate therapeutic regimens for cryptosporidiosis in the immunocompromised host.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3666958      PMCID: PMC259959          DOI: 10.1128/iai.55.11.2669-2674.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.

Authors:  G D Stockman; L R Heim; M A South; J J Trentin
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

2.  Extended schizogony of Eimeria mivati in betamethasone-treated chickens.

Authors:  P L Long; M E Rose
Journal:  Parasitology       Date:  1970-02       Impact factor: 3.234

3.  Genetic differences in the cyclophosphamide-induced immune suppression: weaker suppression of T-cell cytotoxicity by cyclophosphamide activated by CBA mice.

Authors:  M Hurme; B E Bång; M Sihvola
Journal:  Clin Immunol Immunopathol       Date:  1980-09

4.  Attempted chemoprophylaxis of cryptosporidiosis in calves.

Authors:  H W Moon; G N Woode; F A Ahrens
Journal:  Vet Rec       Date:  1982-02-20       Impact factor: 2.695

5.  Cryptosporidium: evidence for a single-species genus.

Authors:  S Tzipori; K W Angus; I Campbell; E W Gray
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

6.  Experimental cryptosporidiosis in laboratory mice.

Authors:  D Sherwood; K W Angus; D R Snodgrass; S Tzipori
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

7.  The therapeutic effect of 16 antimicrobial agents on Cryptosporidium infection in mice.

Authors:  S R Tzipori; I Campbell; K W Angus
Journal:  Aust J Exp Biol Med Sci       Date:  1982-04

8.  Chronic malabsorption due to cryptosporidiosis in a child with immunoglobulin deficiency.

Authors:  K S Sloper; R R Dourmashkin; R B Bird; G Slavin; A D Webster
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

9.  Successful treatment and prevention of murine Pneumocystis carinii pneumonitis with 4,4'-sulfonylbisformanilide.

Authors:  W T Hughes; B L Smith; D P Jacobus
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

10.  Cryptosporidiosis of man and calf: a case report and results of experimental infections in mice and rats.

Authors:  N C Reese; W L Current; J V Ernst; W S Bailey
Journal:  Am J Trop Med Hyg       Date:  1982-03       Impact factor: 2.345

View more
  18 in total

1.  Effectiveness of dehydroepiandrosterone in reduction of cryptosporidial activity in immunosuppressed rats.

Authors:  K R Rasmussen; M J Arrowood; M C Healey
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs.

Authors:  V McDonald; R Stables; D C Warhurst; M R Barer; D A Blewett; H D Chapman; G M Connolly; P L Chiodini; K P McAdam
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

3.  Histopathological method for diagnosis of cryptosporidiosis using monoclonal antibodies.

Authors:  A Bonnin; T Petrella; J F Dubremetz; J F Michiels; D Puygauthier-Toubas; P Camerlynck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

4.  New mouse models for chronic Cryptosporidium infection in immunodeficient hosts.

Authors:  B L Ungar; J A Burris; C A Quinn; F D Finkelman
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

5.  A new antigen of Cryptosporidium parvum micronemes possessing epitopes cross-reactive with macrogamete granules.

Authors:  A Bonnin; J F Dubremetz; P Camerlynck
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

6.  Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice.

Authors:  V McDonald; R Deer; S Uni; M Iseki; G J Bancroft
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

7.  Experimental Cryptosporidium parvum infections in immunosuppressed adult mice.

Authors:  K R Rasmussen; M C Healey
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidines.

Authors:  B L Blagburn; C A Sundermann; D S Lindsay; J E Hall; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 9.  Cryptosporidiosis.

Authors:  W L Current; L S Garcia
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

10.  Persistent cryptosporidiosis in horses with severe combined immunodeficiency.

Authors:  J M Bjorneby; D R Leach; L E Perryman
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.